Alternative approach of hepatocellular carcinoma surveillance: abbreviated MRI

Abstract

This review focuses on emerging abbreviated magnetic resonance imaging (AMRI) surveillance of patients with chronic liver disease for hepatocellular carcinoma (HCC). This surveillance strategy has been proposed as a high-sensitivity alternative to ultrasound for identification of patients with early-stage HCC, particularly in patients with cirrhosis or obesity, in whom sonographic visualization of small tumors may be compromised. Three general AMRI approaches have been developed and studied in the literature - non-contrast AMRI, dynamic contrast-enhanced AMRI, and hepatobiliary phase contrast-enhanced AMRI - each comprising a small number of selected sequences specifically tailored for HCC detection. The rationale, general technique, advantages and disadvantages, and diagnostic performance of each AMRI approach is explained. Additionally, current gaps in knowledge and future directions are discussed. Based on emerging evidence, we cautiously recommend the use of AMRI for HCC surveillance in situations where ultrasound is compromised.

Keywords

Abbreviated magnetic resonance imaging / cirrhosis / Hepatitis B / hepatocellular carcinoma / surveillance / magnetic resonance imaging

References

[1] Zhang BH,Tang ZY.Randomized controlled trial of screening for hepatocellular carcinoma..J Cancer Res Clin Oncol2004;130:417-22

[2] Pascual S,Bernabé JM,Planells M.Surveillance and diagnosis of hepatocellular carcinoma: a systematic review..World J Clin Cases2019;716:2269-86 PMCID:PMC6718786

[3] Ronot M,Dioguardi Burgio M,Nahon P.Hepatocellular carcinoma surveillance with ultrasound - cost-effectiveness, high-risk populations, uptake..Br J Radiol2018;91:20170436 PMCID:PMC6350474

[4] European Association for the Study of the LiverEASL Clinical Practice Guidelines: management of hepatocellular carcinoma..J Hepatol2018;69:182-236

[5] Omata M,Kokudo N,Lee JM.Asia-pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update..Hepatol Int2017;11:317-70 PMCID:PMC5491694

[6] Marrero JA,Sirlin CB,Finn RS.Diagnosis, staging, and management of hepatocellular carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases..Hepatology2018;68:723-50

[7] Kokudo N,Hasegawa K,Kubo S.Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update..Hepatology Res2019;4910:1109-13

[8] Korean Liver Cancer Association (KLCA); National Cancer Center (NCC), Goyang, Korea2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma..Korean J Radiol2019;13:227-99

[9] LI-RADS. American College of Radiology; Available from: https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/LI-RADS. [Last accessed on 13 Jul 2020]

[10] Kim TH,Tang A.Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update..Clin Mol Hepatol2019;25:245-63 PMCID:PMC6759428

[11] Colli A,Casazza G,Colucci A.Accuracy of ultrasonography, Spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review..Am J Gastroenterol2006;10:513-23

[12] Kim SY,Lim YS,Lee JY.MRI with liver-specific contrast for surveillance of patients with cirrhosis at high risk of hepatocellular carcinoma..JAMA Oncol2017;3:456-63 PMCID:PMC5470420

[13] Singal A,Waljee A,Higgins P.Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis..Aliment Pharmacol Ther2009;30:37-47 PMCID:PMC6871653

[14] Tzartzeva K,Rich NE,Marrero JA.Surveillance Imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis..Gastroenterology2018;154:1706-18.e1 PMCID:PMC5927818

[15] Yu NC,Raman SS,Tong MJ.CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis..Clin Gastroenterol Hepatol2011;9:161-7

[16] Colli A,Casazza G,Colucci A.Accuracy of ultrasonography, Spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review..Am J Gastroenterol2006;101:513-23

[17] Samoylova ML,Roberts JP.Predictors of ultrasound failure to detect hepatocellular carcinoma..Liver Transpl2018;24:1171-7

[18] Singal AG,Volk ML,Fontana RJ.Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis..Cancer Epidemiol Biomarkers Prev2012;21:793-9 PMCID:PMC5640437

[19] Hanna RF,Tang A,Brejt SZ.Comparative 13-year meta-analysis of the sensitivity and positive predictive value of ultrasound, CT, and MRI for detecting hepatocellular carcinoma..Abdom Radiol (NY)2016;41:71-90

[20] Forner A,de Lope CR.Current strategy for staging and treatment: the BCLC update and future prospects..Semin Liver Dis2010;30:61-74

[21] Balogh J,Asham EH,Boktour M.Hepatocellular carcinoma: a review..J Hepatocell Carcinoma2016;3:41-53 PMCID:PMC5063561

[22] Singal AG,Yopp A.Screening process failures for hepatocellular carcinoma..J Natl Compr Canc Netw2014;12:375-82 PMCID:PMC5606237

[23] Kim YK,Park HJ,Lee WJ.Noncontrast MRI with diffusion-weighted imaging as the sole imaging modality for detecting liver malignancy in patients with high risk for hepatocellular carcinoma..Magn Reson Imaging2014;32:610-8

[24] Han S,Park MY,Rha SE.The diagnostic performance of liver MRI without intravenous contrast for detecting hepatocellular carcinoma: a case-controlled feasibility study..Korean J Radiol2018;19:568-77 PMCID:PMC6005954

[25] Chan MV,Ong YY,Ho E.HCC screening: assessment of an abbreviated non-contrast MRI protocol..Eur Radiol Exp2019;3:49 PMCID:PMC6920271

[26] Lee JY,Weinstein S,Monto A.Evaluation of an abbreviated screening MRI protocol for patients at risk for hepatocellular carcinoma..Abdom Radiol (NY)2018;43:1627-33

[27] Khatri G,Ananthakrishnan L,Fetzer DT.Abbreviated-protocol screening MRI vs. complete-protocol diagnostic MRI for detection of hepatocellular carcinoma in patients with cirrhosis: An equivalence study using LI-RADS v2018..J Magn Reson Imaging2020;51:415-25

[28] Marks RM,Heba ER,Wolfson TJ.Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance..AJR Am J Roentgenol2015;204:527-35

[29] Besa C,Pandharipande PV,Kamath A.Hepatocellular carcinoma detection: diagnostic performance of a simulated abbreviated MRI protocol combining diffusion-weighted and T1-weighted imaging at the delayed phase post gadoxetic acid..Abdom Radiol2017;42:179-90

[30] Tillman BG,Hru JM,King MC.Diagnostic per-lesion performance of a simulated gadoxetate disodium-enhanced abbreviated MRI protocol for hepatocellular carcinoma screening..Clin Radiol2018;73:485-93

[31] Brunsing RL,Schlein A,Gamst A.Gadoxetate-enhanced abbreviated MRI for hepatocellular carcinoma surveillance: preliminary experience..Radiol Imaging Cancer2019;1:e190010

[32] Park SH,Kim SY,Kim JH.Abbreviated MRI with optional multiphasic CT as an alternative to full-sequence MRI: LI-RADS validation in a HCC-screening cohort..Eur Radiol2020;30:2302-11

[33] Canellas R,Taouli B,Saini S.Abbreviated MRI protocols for the abdomen..Radiographics2019;39:744-58

[34] Sutherland T,Ryan M,Temple F.Diffusion-weighted MRI for hepatocellular carcinoma screening in chronic liver disease: direct comparison with ultrasound screening..J Med Imaging Radiat Oncol2017;61:34-9

[35] Hecht EM,Israel GM,Kim DC.Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis..Radiology2006;239:438-47

[36] McNamara MM,Alexander LF,Bolus DN.Diffusion-weighted MRI as a screening tool for hepatocellular carcinoma in cirrhotic livers: correlation with explant data-a pilot study..Abdom Radiol (NY)2018;43:2686-92

[37] Lima PH,Bérubé J,Olivié D.Cost-utility analysis of imaging for surveillance and diagnosis of hepatocellular carcinoma..AJR Am J Roentgenol2019;17:1-9

[38] Cerny M,Billiard JS,Olivié D.LI-RADS for MR imaging diagnosis of hepatocellular carcinoma: performance of major and ancillary features..Radiology2018;288:118-28

[39] Park MS,Patel J,Do RKG.Hepatocellular carcinoma: detection with diffusion-weighted versus contrast-enhanced magnetic resonance imaging in pretransplant patients..Hepatology2012;56:140-8

[40] Zhang T,Wei Y,Chen J.Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?.World J Gastroenterol2019;25:622-31 PMCID:PMC6371008

[41] Basha MAA,Mohammad FF,El-Maghraby AM.The utility of diffusion-weighted imaging in improving the sensitivity of LI-RADS classification of small hepatic observations suspected of malignancy..Abdom Radiol2019;44:1773-84

[42] Min JH,Choi SY,Lee WJ.Differentiation between cholangiocarcinoma and hepatocellular carcinoma with target sign on diffusion-weighted imaging and hepatobiliary phase gadoxetic acid-enhanced MR imaging: classification tree analysis applying capsule and septum..Eur J Radiol2017;92:1-10

[43] Park HJ,Park MJ.Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma..Abdom Imaging2013;38:793-801

[44] Kanda T,Kawaguchi H,Takenaka D.High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material..Radiology2013;270:834-41

[45] Choi JW.Gadolinium deposition in the brain: current updates..Korean J Radiol2019;20:134-47 PMCID:PMC6315073

[46] Reiter T,Prince MR,Wanner C.Minimizing risk of nephrogenic systemic fibrosis in cardiovascular magnetic resonance..J Cardiovasc Magn Reson2012;14:31 PMCID:PMC3409035

[47] Shankar S,Bhatia A,Singh P.Role of diffusion weighted imaging (DWI) for hepatocellular carcinoma (HCC) detection and its grading on 3T MRI: a prospective study..J Clin Exp Hepatol2016;6:303-10 PMCID:PMC5157886

[48] Chandarana H.Diffusion and perfusion imaging of the liver..Eur J Radiol2010;76:348-58

[49] Saito K,Sugimoto K,Saguchi T.Histological grade of differentiation of hepatocellular carcinoma: comparison of the efficacy of diffusion-weighted MRI with T2-weighted imaging and angiography-assisted CT..J Med Imaging Radiat Oncol2012;56:261-9

[50] An C,Choi JY,Roh YH.Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial..BMC Cancer2018;24:18 PMCID:PMC6154402

[51] Pinho DF,Awdeh H,Khatri G.Optimization of breathing instructions and timing of late arterial phase acquisition on gadobutrol-enhanced MRI of the liver..Clinical Imaging2016;40:1274-9

[52] Contrast Manual. American College of Radiology; 2020. Available from: https://www.acr.org/Clinical-Resources/Contrast-Manual. [Last accessed on 13 Jul 2020]

[53] Wald C,Heimbach JK,Pomfret EA.New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma..Radiology2013;266:376-82

[54] Ultrasound LI-RADS v2017. American College of Radiology. Available from: https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/LI-RADS/Ultrasound-LI-RADS-v2017. [Last accessed on 13 Jul 2020]

[55] Nassif A,Keiser M,Modess C.Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging..Radiology2012;264:741-50

[56] Sano K,Motosugi U,Muhi AM.Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging..Radiology2011;261:834-44

[57] Rosenkrantz AB,Wehrli N,Kim S.New OPTN/UNOS classification system for nodules in cirrhotic livers detected with MR imaging: effect on hepatocellular carcinoma detection and transplantation allocation..Radiology2014;274:426-33

[58] Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis - Full Text View - ClinicalTrials.gov. Available from: http://clinicaltrials.gov/ct2/show/NCT04288323. [Last accessed on 13 Jul 2020]

[59] Goossens N,King LY,Fuchs BC.Cost-effectiveness of risk score-stratified hepatocellular carcinoma screening in patients with cirrhosis..Clin Transl Gastroenterol2017;8:e101 PMCID:PMC5518949

[60] Goldberg DS,Serper M,Dieperink E.Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis..Hepatology2017;65:864-74

[61] Chalasani N,Said A,Kopecky KK.Screening for hepatocellular carcinoma in patients with advanced cirrhosis..Am J Gastroenterol1999;94:2988-93

[62] Goldberg D,Kamalakar R,Babajanyan S.Hepatocellular carcinoma surveillance among cirrhotic patients with commercial health insurance..J Clin Gastroenterol2016;50:258-65

[63] Zech CJ,Berg T,Chau GY.Consensus report from the 8th international forum for liver magnetic resonance imaging..Eur Radiol2020;30:370-82 PMCID:PMC6890618

[64] Breuer FA,Mueller MF,Heidemann RM.Controlled aliasing in volumetric parallel imaging (2D CAIPIRINHA)..Magn Reson Med2006;55:549-56

[65] Low RN,Panchal NJ.High-resolution double arterial phase hepatic MRI using adaptive 2D centric view ordering: initial clinical experience..AJR Am J Roentgenol2010;194:947-56

[66] Ikram NS,Weinstein S,Corvera CU.Multiple arterial phase MRI of arterial hypervascular hepatic lesions: improved arterial phase capture and lesion enhancement..Abdom Radiol (NY).2017;42:870-6 PMCID:PMC5357156

[67] Brodsky EK,Johnson KM,Schelman WR.High spatial and high temporal resolution dynamic contrast-enhanced perfusion imaging of the liver with time-resolved 3D-radial MRI..Magn Reson Med2014;71:934-41 PMCID:PMC3779534

[68] Saranathan M,Hargreaves BA,Vasanawala SS.Differential subsampling with cartesian ordering (DISCO): a high spatio-temporal resolution dixon imaging sequence for multiphasic contrast enhanced abdominal imaging..J Magn Reson Imaging2012;35:1484-92 PMCID:PMC3354015

[69] Shaikh J,Levine EG,Saranathan M.View-sharing artifact reduction with retrospective compressed sensing reconstruction in the context of contrast-enhanced liver MRI for hepatocellular carcinoma (HCC) screening..J Magn Reson Imaging2019;49:984-93

[70] Xu B,Chen G,Nguyen TD.Fast 3D contrast enhanced MRI of the liver using temporal resolution acceleration with constrained evolution reconstruction..Magn Reson Med2013;69:370-81

[71] Cheng JY,Ruangwattanapaisarn N,Uecker M.Free-breathing pediatric MRI with nonrigid motion correction and acceleration..J Magn Reson Imaging2015;42:407 PMCID:PMC4404177

[72] Hedderich DM,Spiro JE,Beck GM.Clinical evaluation of free-breathing contrast-enhanced T1w MRI of the liver using pseudo golden angle radial k-space Sampling..Rofo2018;190:601-9

[73] Zeng DY,Holmes S,Pauly JM.Deep residual network for off-resonance artifact correction with application to pediatric body MRA with 3D cones. Magnetic Resonance in Medicine..Magn Reson Med2019;82:1398-411 PMCID:PMC6626585 (available on 2020-10-01)

[74] Kim YC,Kim YK,Ahn S.Intra-individual comparison of gadolinium-enhanced MRI using pseudo-golden-angle radial acquisition with gadoxetic acid-enhanced MRI for diagnosis of HCCs using LI-RADS..Eur Radiol2019;29:2058-68

[75] Choi JS,Chung YE,Choi JY.Comparison of breathhold, navigator-triggered, and free-breathing diffusion-weighted MRI for focal hepatic lesions..J Magn Reson Imaging2013;38:109-18

[76] Szklaruk J,Wei W,Javadi S.Comparison of free breathing and respiratory triggered diffusion-weighted imaging sequences for liver imaging..World J Radiol2019;11:134-43 PMCID:PMC6885723

[77] Ichikawa S,Tamada D,Sato K.Improving the quality of diffusion-weighted imaging of the left hepatic lobe using weighted averaging of signals from multiple excitations..Magn Reson Med Sci2019;18:225-32 PMCID:PMC6630049

[78] Zhang Y,Holmes JH.Motion-robust and blood-suppressed M1-optimized diffusion MR imaging of the liver..Magn Reson Med2019;82:302-11

[79] Rauh SS,Ohlmeyer S,Saake M.A mixed waveform protocol for reduction of the cardiac motion artifact in black-blood diffusion-weighted imaging of the liver..Magn Reson Imaging2020;67:59-68

[80] Aliotta E,Ennis DB.Convex optimized diffusion encoding (CODE) gradient waveforms for minimum echo time and bulk motion-compensated diffusion-weighted MRI..Magn Reson Med2017;77:717-29

[81] Aliotta E,Ennis DB.Eddy current-nulled convex optimized diffusion encoding (EN-CODE) for distortion-free diffusion tensor imaging with short echo times..Magn Reson Med2018;79:663-72

[82] Hasenstab KA,Higaki A,Wang K.Fully automated convolutional neural network-based affine algorithm improves liver registration and lesion co-localization on hepatobiliary phase T1-weighted MR images..Eur Radiol Exp2019;3:43 PMCID:PMC6815316

[83] Chen F,Taviani V,Brunsing RL.Data-driven self-calibration and reconstruction for non-cartesian wave-encoded single-shot fast spin echo using deep learning..J Magn Reson Imaging2020;51:841-53

[84] Cunha GM,Higaki A,Delgado T.Convolutional neural network-automated hepatobiliary phase adequacy evaluation may optimize examination time..Eur J Radiol2020;124:108837 PMCID:PMC7309446